Highlander Capital Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Highlander Capital Management’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-9,500	Closed	-$52K	–	797
2016 Q3	$52K	Hold	9,500	–	–	0.05%	340
2016 Q2	$36K	Hold	9,500	–	–	0.03%	421
2016 Q1	$26K	Sell	9,500 -5,000	-34%	-$18.1K	0.02%	473
2015 Q4	$82K	Sell	14,500 -2,500	-15%	-$15.2K	0.08%	275
2015 Q3	$90K	Buy	+17,000	New	+$132K	0.09%	254
2015 Q2	–	Sell	-15,000	Closed	-$69K	–	872
2015 Q1	$69K	Buy	+15,000	New	+$48.8K	0.06%	321

Other funds holding SGYP

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Highlander Capital Management's SGYP Position: Q4 2016 in Review

Highlander Capital Management sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2016, closing a stake of 9,500 shares — an estimated $52K sold.

Highlander Capital Management first reported a position in SGYP in Q1 2015 and held it in 6 quarters. The position peaked at $90K in Q3 2015. 156 funds tracked by Wall St. Rank hold SGYP as of Q4 2016.

Highlander Capital Management reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2016 after selling out during the quarter.
Highlander Capital Management sold 9,500 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2016, an estimated $52K.
Highlander Capital Management first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q1 2015 and held it in 6 quarters.
Highlander Capital Management's Synergy Pharmaceuticals, Inc Common Stock position peaked at $90K in Q3 2015.
156 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2016.

Based on Highlander Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.